5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA

5610417 IN-VITRO REAL-TIME OBSERVATION OF MODERATE SICKLING KINETICS IN SICKLE ERYTHROCYTES TREATED BY VOXELOTOR UNDER MONOTONIC AND CYCLIC HYPOXIA

Bibliographic Details
Main Authors:	Y.Q. Qiang, M.D. Dao
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000928224.22861.9f

Similar Items

P1450: VOXELOTOR TREATMENT LEADS TO IMPROVED VIABILITY OF SICKLE ERYTHROCYTES
by: Kadère Konté, et al.
Published: (2023-08-01)

Practical Guidance for the Use of Voxelotor in the Management of Sickle Cell Disease
by: Barriteau CM, et al.
Published: (2022-11-01)

Biophysical chemistry behind sickle cell anemia and the mechanism of voxelotor action
by: Mohd. Suhail
Published: (2024-01-01)

5559749 A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2023-04-01)

Modeling the public health impact of voxelotor in the management of sickle cell disease in France.
by: Frédéric Galacteros, et al.
Published: (2023-01-01)

Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease
by: Paul Telfer, et al.
Published: (2018-05-01)

P1485: A MULTICENTER, RETROSPECTIVE STUDY ON REAL-WORLD EXPERIENCE OF PATIENTS WITH SICKLE CELL DISEASE TREATED WITH VOXELOTOR
by: B. Andemariam, et al.
Published: (2022-06-01)

Voxelotor versus other therapeutic options for sickle cell disease: Are we still lagging behind in treating the disease?
by: Syeda Tayyaba Rehan, et al.
Published: (2022-07-01)

Recent Advances in Sickle-Cell Disease Therapies: A Review of Voxelotor, Crizanlizumab, and L-glutamine
by: Michael Migotsky, et al.
Published: (2022-09-01)

P1432: PATTERNS OF VOXELOTOR USE IN A MULTICENTER, REAL-WORLD STUDY OF PATIENTS WITH SICKLE CELL DISEASE
by: Biree Andemariam, et al.
Published: (2023-08-01)

Model‐informed drug development of voxelotor in sickle cell disease: Population pharmacokinetics in whole blood and plasma
by: Radojka M. Savic, et al.
Published: (2022-06-01)

REAL-WORLD DATA ON THE TREATMENT OF SICKLE CELL DISEASE WITH VOXELOTOR: RESULTS FROM A BRAZIL'S EARLY ACCESS PROGRAM
by: RD Cancado, et al.
Published: (2023-10-01)

Faster Sickling Kinetics and Sickle Cell Shape Evolution during Repeated Deoxygenation and Oxygenation Cycles
by: Du, E., et al.
Published: (2021)

Faster Sickling Kinetics and Sickle Cell Shape Evolution during Repeated Deoxygenation and Oxygenation Cycles
by: Du, E., et al.
Published: (2022)

S279: EFFECT OF VOXELOTOR ON CEREBRAL PERFUSION AND CEREBRAL OXYGEN METABOLISM IN ADULT PATIENTS WITH SICKLE CELL DISEASE; THE COVERAGE STUDY
by: Kadère Konté, et al.
Published: (2023-08-01)

Case report: Safety and efficacy of voxelotor in a patient with sickle cell disease and stage IV chronic kidney disease
by: Awni Alshurafa, et al.
Published: (2022-09-01)

In vitro effect of Allopurinol on sickling rate and uric acid level in sickle cell erythrocyte.
by: Johnkennedy Nnodim
Published: (2013-06-01)

Voxelotor improves red blood cell functionality in children with sickle cell anaemia: An ancillary study of the HOPE‐KIDS 1 trial
by: Satheesh Chonat, et al.
Published: (2024-02-01)

More Unnecessary Imaginary Worlds – Part 4: The ICER Evidence Report for Crizanlizumab, Voxelotor and L-Glutamine for Sickle Cell Disease
by: Paul Langley
Published: (2020-05-01)

Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action
by: Michelle L. Green, et al.
Published: (2022-06-01)

P-013: VOXELOTOR REDUCES SICKLE RED BLOOD CELL-MEDIATED HYPOXIC MICROVASCULAR OCCLUSION AS MEASURED BY OCCLUSIONCHIP IN VITRO MICROFLUIDIC ASSAY
by: SEKYONDA Z., et al.
Published: (2022-08-01)

Erythrocyte membrane ATPase activity in Sickle cell crisis
by: Debapriya Rath
Published: (2017-08-01)

A framework of computer vision-enhanced microfluidic approach for automated assessment of the transient sickling kinetics in sickle red blood cells
by: Yuhao Qiang, et al.
Published: (2024-03-01)

Simultaneous polymerization and adhesion under hypoxia in sickle cell disease
by: Papageorgiou, Dimitrios P, et al.
Published: (2021)

Simultaneous polymerization and adhesion under hypoxia in sickle cell disease
by: Papageorgiou, Dimitrios P., et al.
Published: (2019)

Decreased free Mg2+ and pH in sickle erythrocytes
by: Willcocks, J, et al.
Published: (2000)

Effect of Methanolic Extract of Cassia Fistula to Prevent Erythrocyte Sickling
by: Nazanin Heidari, et al.
Published: (2023-04-01)

Erythrocyte oxidative stress markers in children with sickle cell disease
by: Priscila Bacarin Hermann, et al.
Published: (2016-07-01)

Erythrocyte oxidative stress markers in children with sickle cell disease
by: Priscila Bacarin Hermann, et al.
Published: (2016-07-01)

Erythrocyte oxidative stress markers in children with sickle cell disease
by: Priscila Bacarin Hermann, et al.
Published: (2016-08-01)

S118: LONG-TERM SAFETY AND EFFICACY OF VOXELOTOR FOR PATIENTS WITH SICKLE CELL DISEASE: RESULTS FROM AN OPEN-LABEL EXTENSION OF THE PHASE 3 HOPE TRIAL
by: M Achebe, et al.
Published: (2022-01-01)

Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis
by: Du, E, et al.
Published: (2015)

Optical measurement of biomechanical properties of individual erythrocytes from a sickle cell patient
by: Byun, HeeSu, et al.
Published: (2016)

Patient-specific modeling of individual sickle cell behavior under transient hypoxia
by: Li, Xuejin, et al.
Published: (2017)

Patient-specific modeling of individual sickle cell behavior under transient hypoxia.
by: Xuejin Li, et al.
Published: (2017-03-01)

LIN28A expression reduces sickling of cultured human erythrocytes.
by: Jaira F de Vasconcellos, et al.
Published: (2014-01-01)

The genomic analysis of erythrocyte microRNA expression in sickle cell diseases.
by: Shao-Yin Chen, et al.
Published: (2008-06-01)

Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes.
by: Jeff Spector, et al.
Published: (2016-01-01)

Effect of Caffeine on the Polymerization of HbS and Sickling Rate Osmotic Fragility of HbS Erythrocytes
by: A A UWAKWE, et al.
Published: (2004-02-01)

TSH Receptor Reduces Hemoglobin S Polymerization and Increases Deformability and Adhesion of Sickle Erythrocytes
by: Evelyn Mendonça-Reis, et al.
Published: (2024-01-01)